6533b823fe1ef96bd127eb2e

RESEARCH PRODUCT

The role of the reporting framework MIATA within current efforts to advance immune monitoring

Sylvia JanetzkiCedrik M. BrittenCedrik M. BrittenMark M. DavisAxel HoosChristoph HuberSylvia JanetzkiMichael KalosHyam I. LevitskyHolden T. MaeckerCornelius J.m. MeliefJill O'donnell-tormeyKunle OdunsiLloyd OldChristian OttensmeierBart O. RoepPedro RomeroSjoerd Van Der BurgSteffen Walter

subject

Quality Controlmedicine.medical_specialtyLaboratory Proficiency TestingConsensusmedicine.medical_treatmentInternational CooperationT-LymphocytesImmunologyImmune monitoringPharmacologyImmunologic TestsImmune assaysMonitoring ImmunologicPredictive Value of TestsmedicineImmunology and AllergyHumansCooperative BehaviorIntensive care medicineImmune monitoringObserver Variationbusiness.industryGuideline adherenceMIATAImmunologic TestsReproducibility of ResultsImmunotherapyTreatment OutcomeReportingPredictive value of testsPractice Guidelines as TopicCooperative behaviorLaboratory Proficiency TestingGuideline AdherenceImmunotherapyCurrent (fluid)businessLaboratories
yearjournalcountryeditionlanguage
2014-07-31
10.1016/j.jim.2014.05.003https://doi.org/10.1016/j.jim.2014.05.003